To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Pfizer Investigational Site, Chatswood

Pfizer Investigational Site, Westmead

Pfizer Investigational Site, Duffel

Pfizer Investigational Site, Deakin

Pfizer Investigational Site, Durban

Pfizer Investigational Site, Maroochydore

Pfizer Investigational Site, Woodville

Pfizer Investigational Site, Parow

Pfizer Investigational Site, Girona

Pfizer Investigational Site, Donostia / San Sebastian

Pfizer Investigational Site, Dijon

Pfizer Investigational Site, Hamburg

Pfizer Investigational Site, Pavia

Pfizer Investigational Site, Tours

Pfizer Investigational Site, Seville

Pfizer Investigational Site, Mönchengladbach

Pfizer Investigational Site, Münster

Pfizer Investigational Site, Florence

Pfizer Investigational Site, Mainz

Pfizer Investigational Site, Pisa

Pfizer Investigational Site, Roubaix

Pfizer Investigational Site, Lyon

Pfizer Investigational Site, Paris

Pfizer Investigational Site, Paris

Pfizer Investigational Site, Freiburg im Breisgau

Pfizer Investigational Site, Erlangen

Pfizer Investigational Site, Heidelberg

Pfizer Investigational Site, Graz

Pfizer Investigational Site, Innsbruck

Pfizer Investigational Site, Helsinki

Pfizer Investigational Site, Turku

Pfizer Investigational Site, Göttingen

Pfizer Investigational Site, Munich

Pfizer Investigational Site, Perugia

Pfizer Investigational Site, Heemstede

Pfizer Investigational Site, Heeze

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Gothenburg

Pfizer Investigational Site, Lavigny, LE

Pfizer Investigational Site, Tschugg

Pfizer Investigational Site, Bimingham

Pfizer Investigational Site, Bucks

Pfizer Investigational Site, Dundee

Pfizer Investigational Site, Glasgow

Pfizer Investigational Site, Liverpool

Pfizer Investigational Site, York